SCHEMBL30664665

SCHEMBL30664665

COC(=O)c1c(N(Cc2ccccc2F)C(C)=O)sc2c(Cl)c(O)ccc12

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 5/20 0.38
▸ HSP90B1 P14625 2/20 0.38
▸ KMT2A Q03164 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ TSPO P30536 2/20 0.34
▸ PKM P14618 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HTT P42858 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ CLCN2 P51788 1/20 0.33
▸ NR4A2 P43354 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24683191 1.00 HSP90AA1 (0.38) HSP90AA1HSP90B1KMT2AMEN1TSPO
SCHEMBL24682970 0.91 KMT2A (0.36) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL30664668 0.91 HSP90AA1 (0.39) HSP90AA1HSP90B1PKMALDH1A1LMNA
SCHEMBL24683224 0.91 HSP90AA1 (0.39) HSP90AA1HSP90B1PKMALDH1A1LMNA
SCHEMBL29799927 0.90 LMNA (0.38) HSP90AA1HSP90B1KMT2AMEN1TSPO
SCHEMBL24683205 0.90 LMNA (0.38) HSP90AA1HSP90B1KMT2AMEN1TSPO
SCHEMBL30664726 0.89 HSP90AA1 (0.37) HSP90AA1HSP90B1KMT2AMEN1TSPO
SCHEMBL24683855 0.89 HSP90AA1 (0.37) HSP90AA1HSP90B1KMT2AMEN1TSPO
SCHEMBL24683874 0.89 HSP90AA1 (0.35) HSP90AA1HSP90B1KMT2AMEN1TSPO
SCHEMBL29800015 0.89 HSP90AA1 (0.35) HSP90AA1HSP90B1KMT2AMEN1TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 HSP90AA1 890/4885HSP90B1 2446/4885KMT2A 734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback